Literature DB >> 4077926

Activation of type I collagen genes in cultured scleroderma fibroblasts.

T Vuorio, J K Mäkelä, E Vuorio.   

Abstract

Fibroblasts cultured from affected skin areas of five patients with cutaneous scleroderma were found to produce increased amounts of collagen when compared with nonaffected control cells. Total RNA was isolated from the cultures and analyzed for its level of pro alpha 1 (I)collagen mRNA by hybridization of RNA blots with a cloned cDNA probe. The levels of pro alpha 1 (I)collagen mRNAs relative to total RNA were two- to sixfold higher in the samples from affected cells, accounting for the increased synthesis of type I collagen. Cytoplasmic dot hybridizations were performed to measure the cellular content of pro alpha 1 (I)collagen mRNA: up to ninefold increases in the level of this mRNA per cell were found. Upon subculturing, scleroderma fibroblasts were found to reduce gradually the increased synthesis of collagen to the level of nonaffected controls by the tenth passage. The levels of type I collagen mRNAs were also reduced, but more slowly. The results suggest that in scleroderma fibroblasts the genes for type I collagen are activated at procollagen mRNA level or that they are more stable and that the activating factors are lost during prolonged cell culture because cells from affected areas lose their activated state.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077926     DOI: 10.1002/jcb.240280204

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

Review 1.  The promise of transcription profiling for understanding the pathogenesis of scleroderma.

Authors:  D R Strehlow
Journal:  Curr Rheumatol Rep       Date:  2000-12       Impact factor: 4.592

2.  Transcriptional control mechanisms for the expression of type I collagen genes.

Authors:  B de Crombrugghe; T Vuorio; G Karsenty; S Maity; E C Rutheshouser; H Goldberg
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

3.  Axonal regeneration into chronically denervated distal stump. 2. Active expression of type I collagen mRNA in epineurium.

Authors:  J Siironen; V Vuorinen; H S Taskinen; M Röyttä
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

4.  c-Krox, a transcriptional regulator of type I collagen gene expression, is preferentially expressed in skin.

Authors:  P Galéra; M Musso; P Ducy; G Karsenty
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

Review 5.  Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling.

Authors:  Jennifer L Sargent; Michael L Whitfield
Journal:  Expert Rev Clin Immunol       Date:  2011-07       Impact factor: 4.473

6.  Identification of regulators of the myofibroblast phenotype of primary dermal fibroblasts from early diffuse systemic sclerosis patients.

Authors:  Loubna Chadli; Britt Sotthewes; Kejie Li; Stefan N Andersen; Ellen Cahir-McFarland; Marc Cheung; Patrick Cullen; Annemarie Dorjée; Jeska K de Vries-Bouwstra; Tom W J Huizinga; David F Fischer; Jeroen DeGroot; Joanne L Viney; Timothy S Zheng; Jamil Aarbiou; Agnes Gardet
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

7.  Coordinated regulation of type I and type III collagen production and mRNA levels of pro alpha 1(I) and pro alpha 2(I) collagen in cultured morphea fibroblasts.

Authors:  T Vuorio; J K Mäkelä; V M Kähäri; E Vuorio
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

8.  Differential regulation of transcription and transcript stability of pro-alpha 1(I) collagen and fibronectin in activated fibroblasts derived from patients with systemic scleroderma.

Authors:  B Eckes; C Mauch; G Hüppe; T Krieg
Journal:  Biochem J       Date:  1996-04-15       Impact factor: 3.857

9.  Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization.

Authors:  M Sandberg; E Vuorio
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

Review 10.  Engineering Advanced In Vitro Models of Systemic Sclerosis for Drug Discovery and Development.

Authors:  Andrea De Pieri; Benjamin D Korman; Astrid Jüngel; Karin Wuertz-Kozak
Journal:  Adv Biol (Weinh)       Date:  2021-02-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.